Advancement in mRNA Therapeutics and Vaccines: Overcoming RNase-Related Challenges through RNase-free Single-Use Assemblies & Non-Thermal Plasma-based Inhibition

Time: 1:00 pm
day: Day Two


  • Pioneering Non-Thermal Plasma inhibition of RNases as a cutting-edge alternative for ensuring RNase-free single-use bioprocess containers and assemblies, when conventional methods like thermal, irradiation and chemical inactivation fail
  • Elevate mRNA development and manufacturing processes by mitigating the risk of RNase contamination
  • Exploring the inhibition of RNase through ionized air targeted at enzymes, showcasing an innovative approach to safeguarding bioprocess integrity